Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome

被引：3
|
作者：
Moin, Abu Saleh Md [1 ]
Nandakumar, Manjula [1 ]
Sathyapalan, Thozhukat [2 ]
Atkin, Stephen L. [3 ]
Butler, Alexandra E. [1 ]
机构：
[1] Hamad Bin Khalifa Univ HBKU, Qatar Biomed Res Inst QBRI, Qatar Fdn, Diabet Res Ctr DRC, POB 34110, Doha, Qatar
[2] Hull York Med Sch, Acad Endocrinol Diabet & Metab, Kingston Upon Hull, N Humberside, England
[3] Royal Coll Surg Ireland Bahrain, Adliya, Bahrain
来源：
JOURNAL OF TRANSLATIONAL MEDICINE | 2021年 / 19卷 / 01期
关键词：
Biomarkers; Polycystic ovary syndrome; COVID-19; SARS-CoV-2; Platelet degranulation; Coagulation factors;
D O I：
10.1186/s12967-021-02723-7
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] PROGNOSTIC BIOMARKERS OF DISEASE SEVERITY FOR PATIENTS INFECTED WITH CORONAVIRUS COVID-19
    Ma, Bing
    Ryan, Alice
    Varghese, Anu
    Song, Yang
    Zhang, Yuji
    Singh-Basra, Dalwinder
    Simpson, Matthew
    Shabani, Jawad
    Mann, Dean
    Gebru, Etse
    Nanavaty, Uday
    Magaziner, Jay
    Terrin, Michael L.
    Timofte, Irina L.
    CHEST, 2023, 164 (04) : 821A - 822A
  • [22] Study of biomarkers to determine severity and lung damages in COVID-19 patients
    Rosyid, Alfian Nur
    Puspitasari, Arina Dery
    Effendy, Wiwin Is
    Setiawan, Herley Windo
    Bakhtia, Arief
    Marhana, Isnin Anang
    Sensusiati, Anggraini Dwi
    Nugraha, Jusak
    Ami, Muhammad
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (09):
  • [23] The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness
    Keikha, R.
    Hashemi-Shahri, S. M.
    Jebali, A.
    NEUROLOGIA, 2023, 38 (06): : e41 - e51
  • [24] Iron Dysregulation: Unveiling Predictive Biomarkers for Severity in COVID-19 Patients
    Shaghaghi, Zahra
    Hashemi, Seyyed Hamid
    Alvandi, Maryam
    Marzhoseyni, Zeynab
    Ghasemi-Basir, Hamidreza
    Mohamadi, Tayeb
    Farzipour, Soghra
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2024,
  • [25] Macrophages may treat COVID-19 severity
    Devi, Sharmila
    LANCET INFECTIOUS DISEASES, 2022, 22 (11): : 1548 - 1548
  • [26] The causal association between polycystic ovary syndrome and susceptibility and severity of COVID-19: a bidirectional Mendelian randomization study using genetic data
    Si, Yu
    Fei, Yuye
    Ma, Hua
    Xu, Yating
    Ning, Li
    Li, Xiu
    Ren, Qingling
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [27] Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
    Ioannis Kyrou
    Emmanouil Karteris
    Tim Robbins
    Kamaljit Chatha
    Fotios Drenos
    Harpal S. Randeva
    BMC Medicine, 18
  • [28] Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
    Kyrou, Ioannis
    Karteris, Emmanouil
    Robbins, Tim
    Chatha, Kamaljit
    Drenos, Fotios
    Randeva, Harpal S.
    BMC MEDICINE, 2020, 18 (01)
  • [29] The Impact of the COVID-19 Pandemic on Health and Health Care Experience in Those With Polycystic Ovary Syndrome
    Sydora, Beate C.
    Wilke, Michaelann S.
    Ghosh, Mahua
    Vine, Donna F.
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2025, 17 : 287 - 298
  • [30] Increased COVID-19 infections in women with polycystic ovary syndrome: a population- based study
    Subramanian, Anuradhaa
    Anand, Astha
    Adderley, Nicola J.
    Okoth, Kelvin
    Toulis, Konstantinos A.
    Gokhale, Krishna
    Sainsbury, Christopher
    O'Reilly, Michael W.
    Arlt, Wiebke
    Nirantharakumar, Krishnarajah
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 184 (05) : 637 - 645
12345